Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the macular volume of patients treated with a 3-month
course of topical Nepafenac (0.1% solution) to patients treated with a placebo course
following epiretinal membrane surgery.